drugset / Trial / NCT05154136

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

NCT05154136

Phase 1 Completed 20 enrolled Arcus Biosciences, Inc.
NaSequentialOpen-labelTreatment

Summary

This study will evaluate the effect of multiple oral doses of itraconazole, on the pharmacokinetics of etrumadenant when etrumadenant is administered as a single dose in healthy adult participants.

Timeline

Start
2021-10-20
Primary completion
2021-12-10
Completion
2021-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Etrumadenant Small molecule
Subject Itraconazole Small molecule Oral

Indications

No indication recorded.